Protein Replacement Therapy to Improve Patients Lives

Chronic Kidney Disease

Chronic kidney disease (CKD) is the progressive loss of kidney function leading to dialysis or kidney transplant. DM199 is being developed to offer CKD patients a treatment option to improve kidney function by Improving kidney blood flow and reducing inflammation, fibrosis and oxidative stress. DiaMedica is currently studying CKD caused by IgA Nephropathy and in African Americans with CKD.

Acute Ischemic Stroke

Acute ischemic stroke is characterized by the sudden loss of blood flow to the brain, resulting loss of neurologic function. DM199 in development to provide a treatment option for almost all stroke patients.

Acute Ischemic Stroke ›